paroxetine has been researched along with Syndrome in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.67) | 18.7374 |
1990's | 19 (63.33) | 18.2507 |
2000's | 6 (20.00) | 29.6817 |
2010's | 2 (6.67) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Cao, J; Chen, D; Chen, JX; Chen, X; Guo, CL; Han, XY; Hong, X; Jiao, XZ; Jiao, YX; Li, MX; Liang, S; Liu, HM; Meng, S; Qi, JX; Wang, TT; Zhao, Y | 1 |
Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B | 1 |
Nibuya, M; Nomura, S; Takahashi, T | 1 |
Cohen, BM; Frederick, Bd; Hennen, J; Henry, ME; Kaufman, MJ; Renshaw, PF; Schmidt, ME; Stoddard, EP; Villafuerte, RA | 1 |
Burgmer, M; Driesch, G; Heuft, G | 1 |
Hendrix, Y; van Zagten, MS | 1 |
Braam, AW; Cath, DC; Hoogendijk, WJ; Visser, S | 1 |
Ito, H; Narabayashi, M; Nishida, T; Onishi, H; Wada, M | 1 |
Engbaek, F; Lademann, A; Magnussen, I; Mondrup, K; Olivarius, BD | 1 |
Burke, M; Harvey, AT | 1 |
Phillips, SD | 1 |
Brown, TM; Finkelstein, JA; Magoon, MR; Mareth, TR; Skop, BP | 1 |
Domino, EF; Holmes, RD; Lee, A; Markel, H | 1 |
Bastani, AJ; Bastani, JB; Troester, MM | 1 |
König, F; Löble, M; Wolfersdorf, M | 1 |
Blew, PG; John, L; Perreault, MM; Tao, T | 1 |
Cabot, C; Cathala, B; Fabre, M; Robert, P; Senard, JM | 1 |
Adès, J; Lejoyeux, M | 1 |
Haddad, P | 1 |
Haddad, P; Kaplan, EM; Lejoyeux, M; Rosenbaum, JF; Schatzberg, AF; Young, AH; Zajecka, J | 1 |
Peak, DA | 1 |
McKay, CA; Tilden, FF; Weiner, AL | 1 |
Harry, B; Zimmerschied, JA | 1 |
Hoffman, RS; Rella, JG | 1 |
Buchalter, EN; Giambanco, V; Lantz, MS | 1 |
Ackenheil, M; Bottlender, R; Gallinat, J; Hegerl, U; Kuss, HJ; Möller, HJ | 1 |
Abel, L; Holzer, JC; Iqbal, JC | 1 |
Thompson, C | 1 |
D'Addio, K; Prater, JF | 1 |
Koshikawa, N; Smokcum, RW; Stephenson, JD | 1 |
5 review(s) available for paroxetine and Syndrome
Article | Year |
---|---|
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Syndrome | 2015 |
[The "Sisi syndrome": a new form of depression?].
Topics: Advertising; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Industry; Germany; Humans; Marketing; Paroxetine; Syndrome | 2003 |
Antidepressant discontinuation: a review of the literature.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Newer antidepressants and the discontinuation syndrome.
Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
Topics: Down-Regulation; Half-Life; Humans; Neurotransmitter Agents; Norepinephrine; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Syndrome | 1997 |
2 trial(s) available for paroxetine and Syndrome
Article | Year |
---|---|
Efficacy and Safety of Jianpi Jieyu Decoction for Patients with Mild-to-Moderate Depression of Xin (Heart)-Pi (Spleen) Deficiency Syndrome: A Multi-centre Randomized Controlled Study.
Topics: Anxiety; Double-Blind Method; Humans; Medicine, Chinese Traditional; Paroxetine; Spleen; Syndrome; Treatment Outcome | 2023 |
Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study.
Topics: Adult; Brain Mapping; Choline; Depressive Disorder, Major; Female; Fluoxetine; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Paroxetine; Phosphocreatine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome | 2003 |
23 other study(ies) available for paroxetine and Syndrome
Article | Year |
---|---|
Delusion of Cotard's syndrome successfully treated with a dopamine agonist.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Benzothiazoles; Delusions; Depressive Disorder, Major; Dopamine Agonists; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Pramipexole; Recurrence; Syndrome; Treatment Outcome | 2010 |
[Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].
Topics: Aged; Brain Stem; Drug Synergism; Female; Humans; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Syndrome; Treatment Outcome | 2005 |
Investigation of the syndrome of apotemnophilia and course of a cognitive-behavioural therapy.
Topics: Adult; Amputation, Surgical; Body Image; Cognitive Behavioral Therapy; Combined Modality Therapy; Depersonalization; Disabled Persons; Factitious Disorders; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychopathology; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Syndrome | 2006 |
Activation syndrome caused by paroxetine in a cancer patient.
Topics: Akathisia, Drug-Induced; Depressive Disorder, Major; Humans; Male; Middle Aged; Pancreatic Neoplasms; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Syndrome | 2008 |
Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP.
Topics: 5-Hydroxytryptophan; Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myoclonus; Paroxetine; Piperidines; Serotonin; Serotonin Antagonists; Syndrome | 1982 |
Comment on: the serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease.
Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Drug Interactions; Female; Humans; Mixed Function Oxygenases; Paroxetine; Serotonin; Syndrome | 1995 |
A possible paroxetine withdrawal syndrome.
Topics: Adult; Akathisia, Drug-Induced; Female; Headache; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome; Syndrome; Vomiting | 1995 |
The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease.
Topics: Acetaminophen; Acute Disease; Akathisia, Drug-Induced; Blood Platelets; Dextromethorphan; Diagnosis, Differential; Doxylamine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Ephedrine; Humans; Hypertension; Male; Middle Aged; Myoclonus; Nonprescription Drugs; Paroxetine; Peripheral Vascular Diseases; Promethazine; Pseudoephedrine; Sweating; Syndrome | 1994 |
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Drug Interactions; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Recurrence; Sertraline; Substance-Related Disorders; Syndrome | 1994 |
Serotonin syndrome and fluvoxamine: a case study.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Syndrome; Time Factors | 1996 |
[Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzamides; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Trimipramine | 1996 |
Serotonin syndrome associated with nefazodone and paroxetine.
Topics: Antidepressive Agents, Second-Generation; Coma; Drug Synergism; Female; Humans; Hyponatremia; Middle Aged; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Syndrome; Triazoles | 1997 |
[Serotonin syndrome in acute poisoning with antidepressive agents].
Topics: Adult; Antidepressive Agents; Benzamides; Humans; Male; Moclobemide; Muscle Hypertonia; Paroxetine; Serotonin; Syndrome | 1996 |
Toxic effects of nefazodone.
Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Triazoles | 1997 |
Serotonin syndrome: case report and review of the literature.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1997 |
Serotonin syndrome in a prisoner.
Topics: Antidepressive Agents, Second-Generation; Ataxia; Confusion; Depression; Drug Interactions; Forensic Psychiatry; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Prisoners; Psychotropic Drugs; Risk Factors; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
Possible serotonin syndrome from paroxetine and clonazepam.
Topics: Adult; Clonazepam; Contraindications; Drug Interactions; Female; GABA Modulators; Humans; Nervous System Diseases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1998 |
Serotonin syndrome following the administration of tramadol with paroxetine.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Autonomic Nervous System Diseases; Central Nervous System Diseases; Depression; Drug Interactions; Female; Humans; Pain; Paroxetine; Selective Serotonin Reuptake Inhibitors; Syndrome; Tramadol | 1998 |
The serotonin syndrome scale: first results on validity.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Syndrome | 1998 |
Paroxetine and amotivational syndrome.
Topics: Cerebrovascular Disorders; Hemiplegia; Humans; Male; Middle Aged; Motivation; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
Discontinuation of antidepressant therapy: emerging complications and their relevance.
Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Syndrome; Terminology as Topic | 1998 |
Johanson-Blizzard syndrome--a case study, behavioral manifestations, and successful treatment strategies.
Topics: Abnormalities, Multiple; Adult; Aggression; Behavior Therapy; Combined Modality Therapy; Follow-Up Studies; Humans; Intellectual Disability; Male; Obsessive-Compulsive Disorder; Paroxetine; Syndrome | 2002 |
Is waning of a 5-hydroxytryptamine (5-HT)-mediated syndrome due to 5-HT2 receptor down-regulation?
Topics: Animals; Cerebral Cortex; Ketanserin; Male; Myoclonus; Paroxetine; Phenelzine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Syndrome; Time Factors; Tritium | 1985 |